SuicideSPRINGNCT06128239
Comparing Suicide Prevention Interventions to Guide Follow-up Care: The SPRING Trial
A study testing Caring Contacts in people with Suicide and Suicide Prevention, run by St. Luke's Health System, Boise, Idaho at 1 site in United States.
Trial summary
Pragmatic randomized controlled trial to compare the effectiveness of two-way Caring Contacts text messages vs. one-way Caring Contacts text messages vs. enhanced usual care for suicide prevention in adults and adolescents. Read more about this study
- Who is it for?
- Ages 12 years and older
- Conditions the study is for
- Suicide, Suicide Prevention, Suicide and Self-harm
- What is being tested?
- Caring Contacts
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 854 participants
- Where
- 1 siteUnited States
- Study dates
- 29 Dec 2023to 31 Mar 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Adolescents (12-17 years old) and adults (18+)
- Response of "yes" to at least one item on the Columbia Suicide Severity Rating Scale (C-SSRS) six-item screener at a St. Luke's Health System (SLHS) primary care or behavioral health clinic, or electronic health record or provider note from an eligible encounter indicates suicide risk
- Ability to send and receive text messages
- Ability to receive phone calls
- Ability to receive emails
- Participant and legal guardian (if applicable) speak, read, and understand English
- Accommodations may be made for individuals with impaired hearing
Who cannot join
- Individuals who participated in a previous randomized controlled trial in the same health system related to Caring Contacts (SPARC Trial or MHAPPS Trial)
- Patients who are unable or unwilling to provide informed consent*, for example, due to acute or chronic cognitive impairment (i.e.: acute psychosis, intoxication, or intellectual disability).
- Primary Care Provider, Behavioral Health Provider, or Principal Investigator determines that participation in the research is not in the best interest of the patient or the study team.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Comparing the Effectiveness of Two-Way Caring Contacts Texts vs One-Way Caring Contacts Texts vs Enhanced Usual Care to Reduce Suicidal Behavior in Youth and Adults Screening At-Risk for Suicide in Primary Care or Behavioral Health Clinics
Pragmatic randomized controlled trial to compare the effectiveness of two-way Caring Contacts text messages vs. one-way Caring Contacts text messages vs. enhanced usual care for suicide prevention in adults and adolescents.
- Conditions
- Suicide, Suicide Prevention, Suicide and Self-harm
- Being tested
- Caring Contacts
- Keywords
- Caring Contacts, brief contact intervention, adult, adolescent, primary care, behavioral health, follow-up care
- Medical subject headings
- Suicide, Suicide Prevention, Self-Injurious Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Caring ContactsBehavioural
Also called Caring Texts, Caring Letters
Text message version of Motto's Caring Contacts intervention. The study will compare two versions of text-based Caring Contacts: two-way messages, to which participants can respond to receive text-based support from follow-up specialists, and one-way text messages, to which participants cannot respond.
| Study group | Role | What they receive |
|---|---|---|
| Two-Way Caring Contacts Texts (CC2) | Experimental | In addition to receiving enhanced usual care as described below, a series of 25 standardized outgoing Caring Contacts text messages will be sent to participants randomized to the CC2 intervention arm through our online texting platform. To remind participants that they can respond, the outgoing texts will periodically invite replies in a non-demanding way, e.g., "Hope you're doing well this week, Anna. Feel free to text me back if you feel like it, I'm here for you." Responses to CC2 participant replies will be unscripted and individually tailored. Receives: Behavioral: Caring Contacts |
| One-Way Caring Contacts Texts (CC1) | Experimental | In addition to receiving enhanced usual care as described below, CC1 participants will be sent 25 caring texts, such as "Even though know we do not personally know each other, we truly value your wellbeing and are thinking of you. If you'd like to connect with someone, feel free to call or text 988 anytime - their team would be happy to hear from you." CC1 participants will not be able to reply to the texts and the online texting platform will block incoming messages. This will be clearly communicated to CC1 participants during the informed consent process and they will be asked to sign off on understanding this and other key points before enrolling in the study. Receives: Behavioral: Caring Contacts |
| Enhanced Usual Care (UC) | No intervention | Participants randomized to the UC arm will receive best available usual care from the health system, such as standardized clinical assessments, the safety planning intervention or other intervention(s), appropriate referrals and/or medication management through a system wide electronic health record system-assisted suicide care clinical workflow. Usual care will vary based on patient clinical needs, availability of providers/staff, and provider clinical judgment. Following study enrollment, all participants will be given a list of resources, offered a warm hand-off to 988, and encouragement to call or text 988 as needed. During the baseline survey, participants will have the opportunity to opt into a call from the follow-up team to develop or revise a safety plan. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Suicidal behavior
Measured using the Harkavy-Asnis Suicide Scale (HASS) Active Suicidal Behavior Sub-Scale. The HASS has been validated for self-report, with strong psychometric properties in adolescents and adults. This measure asks about the frequency of suicide attempt planning, and actual and aborted/interrupted suicide attempts. Participants respond using the Likert scale response options used by Asarnow et al.'s validation study, modified to fit the survey time period (past six months at baseline/12-month outcome surveys, and past 3 months for 3- and 6-month outcome surveys). Each HASS sub-scale is scored separately by summing the response values. Scores on the Active Suicidal Behavior Sub-Scale range from 0 - 20, with higher scores corresponding to higher suicide risk. The primary outcome will be the cumulative risk of suicidal behavior assessed using area under the curve of the HASS scores over the 12-month study period.
Measured: Baseline, 3 months, 6 months, 12 months
Secondary outcomes (4)
Suicide attempts
Suicide attempts will be measured using the Columbia Suicide Severity Rating Scale (C-SSRS), which is valid for adolescents and adults.
Measured: Baseline, 3 months, 6 months, 12 months
Suicide ideation
Suicidal ideation will be measured using the Passive Suicidal Ideation Subscale of the Harkavy-Asnis Suicide Scale (HASS), which includes 12 items. Scores on the Passive Suicidal Ideation Sub-Scale range from 0 - 48, with higher scores corresponding to higher suicide risk.
Measured: Baseline, 3 months, 6 months, 12 months
Suicide-related Emergency Department (ED) utilization and hospitalization
Suicide-related ED utilization and hospitalization will be assessed by self-report and using electronic medical records. Reason for visit/diagnoses may be reviewed in electronic medical records for any inpatient or outpatient encounters that occur during the study period.
Measured: Baseline, 3 months, 6 months, 12 months
Outpatient mental health treatment
Outpatient mental health treatment will be self-reported and assessed using electronic medical records. Reason for visit/diagnoses may be reviewed in electronic medical records for any inpatient or outpatient encounters that occur during the study period.
Measured: Baseline, 3 months, 6 months, 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Nov 2023
- Study start29 Dec 2023
- Primary completion31 Mar 2026 (estimated)
- Study completion31 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for SuicideStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants randomized 1:1:1 to three treatment conditions
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 854 participants (actual)
Sponsor and investigators
- Lead sponsor
- St. Luke's Health System, Boise, Idaho
- Sponsor type
- University, hospital or other
- Collaborators
- American Foundation for Suicide Prevention, University of Washington, Idaho Crisis & Suicide Hotline
- Responsible party
- Principal investigator, Anna Radin, St. Luke's Health System, Boise, Idaho
- Investigators
- Anna K Radin, DrPH, MPH, Principal investigator, St. Luke's Health System
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06128239
- Sponsor's protocol ID
- 2023-0088
- Other IDs
- TBT-0-022-22
- Acronym
- SPRING
- Status last verified
- Jul 2025
- First submitted
- 7 Nov 2023
- Last updated
- 9 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All data will be uploaded to the National Institutes for Mental Health Data Archive (NDA).
Publications
Radin AK, Brown SP, Shaw J, Fouts T, McCue E, Skeie A, Pierce H, Flint H, Biss M, Sandoval D, Chase K, Davis J, Austin G, Chan KCG, Fruhbauerova M, Ratzliff A, Walton M, Bronner J, McCutchan PK, Comtois KA. Comparative effectiveness of two-way caring contacts texts vs one-way caring contacts texts vs enhanced usual care to reduce suicidal behavior in adolescents and adults: Protocol for the SPRING pragmatic randomized controlled trial. Contemp Clin Trials. 2025 Apr;151:107839. doi: 10.1016/j.cct.2025.107839. Epub 2025 Feb 10.
PubMed 39938610
Study at a glance
From the registry record, last updated by the sponsor on 9 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparing the Effectiveness of Two-Way Caring Contacts Texts vs One-Way Caring Contacts Texts vs Enhanced Usual Care to Reduce Suicidal Behavior in Youth and Adults Screening At-Risk for Suicide in Primary Care or Behavioral Health Clinics
- ClinicalTrials.gov ID
- NCT06128239
- Acronym / sponsor ID
- SPRING / 2023-0088
- Conditions
- Suicide, Suicide Prevention, Suicide and Self-harm
- Keywords
- Caring Contacts, brief contact intervention, adult, adolescent, primary care, behavioral health, follow-up care
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 854 participants (actual)
- Lead sponsor
- St. Luke's Health System, Boise, IdahoUniversity, hospital or other
- Collaborators
- American Foundation for Suicide Prevention, University of Washington, Idaho Crisis & Suicide Hotline
- Study start
- 29 Dec 2023 (actual)
- Primary completion
- 31 Mar 2026 (estimated)
- Study completion
- 31 Mar 2026 (estimated)
- First posted
- 13 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pragmatic randomized controlled trial to compare the effectiveness of two-way Caring Contacts text messages vs. one-way Caring Contacts text messages vs. enhanced usual care for suicide prevention in adults and adolescents.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 3
- Model description
- Participants randomized 1:1:1 to three treatment conditions
| Arm | Type | Receives |
|---|---|---|
| Two-Way Caring Contacts Texts (CC2) | Experimental | Behavioral: Caring ContactsIn addition to receiving enhanced usual care as described below, a series of 25 standardized outgoing Caring Contacts text messages will be sent to participants randomized to the CC2 intervention arm through our online texting platform. To remind participants that they can respond, the outgoing texts will periodically invite replies in a non-demanding way, e.g., "Hope you're doing well this week, Anna. Feel free to text me back if you feel like it, I'm here for you." Responses to CC2 participant replies will be unscripted and individually tailored. |
| One-Way Caring Contacts Texts (CC1) | Experimental | Behavioral: Caring ContactsIn addition to receiving enhanced usual care as described below, CC1 participants will be sent 25 caring texts, such as "Even though know we do not personally know each other, we truly value your wellbeing and are thinking of you. If you'd like to connect with someone, feel free to call or text 988 anytime - their team would be happy to hear from you." CC1 participants will not be able to reply to the texts and the online texting platform will block incoming messages. This will be clearly communicated to CC1 participants during the informed consent process and they will be asked to sign off on understanding this and other key points before enrolling in the study. |
| Enhanced Usual Care (UC) | No intervention | –Participants randomized to the UC arm will receive best available usual care from the health system, such as standardized clinical assessments, the safety planning intervention or other intervention(s), appropriate referrals and/or medication management through a system wide electronic health record system-assisted suicide care clinical workflow. Usual care will vary based on patient clinical needs, availability of providers/staff, and provider clinical judgment. Following study enrollment, all participants will be given a list of resources, offered a warm hand-off to 988, and encouragement to call or text 988 as needed. During the baseline survey, participants will have the opportunity to opt into a call from the follow-up team to develop or revise a safety plan. |
Who may qualify
- Ages
- 12 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (7 listed)
- Adolescents (12-17 years old) and adults (18+)
- Response of "yes" to at least one item on the Columbia Suicide Severity Rating Scale (C-SSRS) six-item screener at a St. Luke's Health System (SLHS) primary care or behavioral health clinic, or electronic health record or provider note from an eligible encounter indicates suicide risk
- Ability to send and receive text messages
- Ability to receive phone calls
- Ability to receive emails
Key exclusion criteria (3 listed)
- Individuals who participated in a previous randomized controlled trial in the same health system related to Caring Contacts (SPARC Trial or MHAPPS Trial)
- Patients who are unable or unwilling to provide informed consent*, for example, due to acute or chronic cognitive impairment (i.e.: acute psychosis, intoxication, or intellectual disability).
- Primary Care Provider, Behavioral Health Provider, or Principal Investigator determines that participation in the research is not in the best interest of the patient or the study team.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Caring ContactsAlso: Caring Texts, Caring LettersText message version of Motto's Caring Contacts intervention. The study will compare two versions of text-based Caring Contacts: two-way messages, to which participants can respond to receive text-based support from follow-up specialists, and one-way text messages, to which participants cannot respond. | Behavioural | One-Way Caring Contacts Texts (CC1), Two-Way Caring Contacts Texts (CC2) |
Primary outcome
Suicidal behavior
Time frame: Baseline, 3 months, 6 months, 12 months
Measured using the Harkavy-Asnis Suicide Scale (HASS) Active Suicidal Behavior Sub-Scale. The HASS has been validated for self-report, with strong psychometric properties in adolescents and adults. This measure asks about the frequency of suicide attempt planning, and actual and aborted/interrupted suicide attempts. Participants respond using the Likert scale response options used by Asarnow et al.'s validation study, modified to fit the survey time period (past six months at baseline/12-month outcome surveys, and past 3 months for 3- and 6-month outcome surveys). Each HASS sub-scale is scored separately by summing the response values. Scores on the Active Suicidal Behavior Sub-Scale range from 0 - 20, with higher scores corresponding to higher suicide risk. The primary outcome will be the cumulative risk of suicidal behavior assessed using area under the curve of the HASS scores over the 12-month study period.
4 secondary outcomes
Suicide attempts
Time frame: Baseline, 3 months, 6 months, 12 months
Suicide ideation
Time frame: Baseline, 3 months, 6 months, 12 months
Suicide-related Emergency Department (ED) utilization and hospitalization
Time frame: Baseline, 3 months, 6 months, 12 months
Outpatient mental health treatment
Time frame: Baseline, 3 months, 6 months, 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jul 2025.
- Derived from this study: PubMed 39938610Radin AK, Brown SP, Shaw J, Fouts T, McCue E, Skeie A, Pierce H, Flint H, Biss M, Sandoval D, Chase K, Davis J, Austin G, Chan KCG, Fruhbauerova M, Ratzliff A, Walton M, Bronner J, McCutchan PK, Comtois KA. Comparative effectiveness of two-way caring contacts texts vs one-way caring contacts texts vs enhanced usual care to reduce suicidal behavior in adolescents and adults: Protocol for the SPRING pragmatic randomized controlled trial. Contemp Clin Trials. 2025 Apr;151:107839. doi: 10.1016/j.cct.2025.107839. Epub 2025 Feb 10.
- Individual participant dataSharing planned: Yes. All data will be uploaded to the National Institutes for Mental Health Data Archive (NDA).
Related trials for Suicide
Not yet recruiting
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Suicidal Ideas, Suicidal Ideation
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
SERENE Low-Intensity Focused Ultrasound for Cognitive Control
Suicidal Ideation, Cognitive Control
Not yet recruiting
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Alcohol Use Disorder (AUD), Suicide Ideation
Enrolling by invitation
Pilot Study of a Modified Safety Planning Intervention for Elementary School-Aged Children - Main Study
Suicidal Ideation, Suicidal Behaviors
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anna K Radin, DrPH, MPH principal investigator
St. Luke's Health System
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Caring Contacts in people with Suicide and Suicide Prevention, run by St. Luke's Health System, Boise, Idaho at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 9 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Suicidal behavior (time frame: Baseline, 3 months, 6 months, 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06128239, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2025.